Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don't know.

Gynecologic oncology - 1 Apr 2016

Liu Joyce, Westin Shannon N

Abstract excerpt

Precision medicine is a rapidly evolving area in the treatment of gynecologic malignancies. Advances in sequencing technology have resulted in an increasing wealth of data regarding the genomic characteristics of ovarian, endometrial, and cervical cancers. These vast new datasets of information have led to novel insights into potential vulnerabilities and therapeutic targets for these cancers. However, unraveling...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, BRCA1
Share to Genes, p53
Share to Genital Neoplasms, Female

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Molecular Targeted Therapy

Share to Phosphoinositide-3 Kinase Inhibitors

Share to Poly(ADP-ribose) Polymerase Inhibitors

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 27016231
DOI: 10.1016/j.ygyno.2016.01.003
PMCID: PMC4808566

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don't know.PMID 27016231Read ↗

Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With CancerSemantic proximity Read ↗

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform.Semantic proximity Read ↗

Molecular Testing for Diagnostics, Prognostication, and Treatment Stratification in Cancers.Semantic proximity Read ↗

Development of New Cancer Treatment by Identifying and Focusing the Genetic Mutations or Altered Expression in Gynecologic Cancers.Semantic proximity Read ↗

Biologic therapies and personalized medicine in gynecologic malignancies.Semantic proximity Read ↗

Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapiesSemantic proximity Read ↗

Molecular profiling of gynecologic cancers for treatment and management of disease - demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants.Semantic proximity Read ↗

The Future of Cancer Diagnosis and Treatment: Unlocking the Power of Biomarkers and Personalized Molecular-Targeted TherapiesSemantic proximity Read ↗

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted TherapySemantic proximity Read ↗

The Precision Oncology Approach to Molecular Cancer Therapeutics Targeting Oncogenic Signalling Pathways Is a Means to an EndSemantic proximity Read ↗

Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord–Stromal Tumors: A Contemporary ReviewSemantic proximity Read ↗

Precision oncology, signaling and targeted therapy: a strategic shift towards a holistic approach to cancer treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.